Leading U.S. cryptocurrency exchange Coinbase has announced plans to list three new altcoins this week: BankrCoin (BNKR), Bio Protocol (BIO), and ResearchCoin (RSC). BNKR has already gone live, immediately jumping nearly 30% in value.
BNKR is the native token of Bankr, an AI-powered automated trading platform. Despite limitations such as low liquidity and high volatility, the Coinbase listing could help the project attract more investor attention. Previously, most of BNKR’s trading volume came from decentralized exchanges (DEXs) and a few centralized ones like Gate.io.
Unlike BNKR, which leans more toward the meme coin category, the other two—BIO and RSC—are focused on the emerging field of decentralized science (DeSci), which blends blockchain technology with scientific research.
Bio Protocol (BIO), launched in early 2025, aims to use decentralized autonomous organizations (DAOs) to fund biotech research. BIO holders can vote on which scientific projects receive funding. The project also plans to mint NFTs based on community-funded discoveries, although it currently lacks formal partnerships with major research institutions.
ResearchCoin (RSC), on the other hand, does not fund research directly but instead promotes scientific awareness among users. Launched in 2022, RSC rewards users for sharing useful research papers and encouraging meaningful discussions within the community. Following the Coinbase listing announcement, RSC’s price surged over 10%, with daily trading volume jumping 200%, according to CoinMarketCap.
By listing tokens in both AI and DeSci sectors, Coinbase is demonstrating a highly diversified asset listing strategy—one that spans cutting-edge technologies and community-driven academic initiatives.
